Article Sidebar

PDF
Date Published: 19/02/2023
Abstract Views: 1404
Views PDF: 212
DOI: https://doi.org/10.51298/vmj.v522i2.4351
Issue
Vol. 522 No. 2 (2023)
Section
Các bài báo
How to Cite
Nguyễn, T. V. ., Nguyễn, T. T. ., & Nguyễn, T. H. . (2023). HISTOPATHOLOGY CHARACTERISTICS AND DISCLOSURE OF CK7, CK20 MARKERS OF PRIMARY UPPER TRACT UROTHELIAL CARCINOMA. Vietnam Medical Journal, 522(2). https://doi.org/10.51298/vmj.v522i2.4351

HISTOPATHOLOGY CHARACTERISTICS AND DISCLOSURE OF CK7, CK20 MARKERS OF PRIMARY UPPER TRACT UROTHELIAL CARCINOMA

Thế Việt Nguyễn1,, Thế Tân Nguyễn2, Thúy Hương Nguyễn3
1 Hanoi medical university
2 National cancer hospital
3 Phenikaa university

Main Article Content

Abstract

Objectives: To describe the histopathology characteristics of upper tract urothelial carcinoma and determine the state of expression of CK7 and CK20 markers. Methods: We conducted a cross-sectional, prospective, and retrospective study on 65 patients with diagnosed primary upper tract urothelial carcinoma according to WHO classification in 2016 from September 2018 to August 2022 at K Hospital. Results: we studied on 65 patients, in which male accounted for 66.2%, female accounted for 33.8%. The mean age was 64.31 ± 9.74. 80.2% of urothelial carcinoma are common, 10.8% with squamous differentiation, 61.5% invaded the muscle layer. The rate of CK7 and CK20 in urothelial carcinoma was 83.1% and 55.4%, respectively. There was no association between CK7 and CK20 co-expression with histology, stage, and muscle invasion of the tumor (p > 0.05).

Article Details

Keywords

Histopathology characteristics, CK7, CK20 markers, upper tract urothelial carcinoma

References

1. Melzer M, Braf Z, Beyar H, Rakowszczyk M. Primary tumors of the renal pelvis and ureter. Int Surg. 1972;57(9):699-702.
2. Azémar MD, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance. Urol Oncol Semin Orig Investig. 2011;29(2):130-136. doi:10.1016/j.urolonc.2009.06.003
3. Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 2019;491:39-45. doi:10.1016/j.cca.2019.01.011
4. Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29(4):481-486. doi:10.1007/s00345-010-0594-7
5. Organisation mondiale de la santé, Centre international de recherche sur le cancer, eds. WHO Classification of Tumours of the Urinary System and Male Genital Organs. International agency for research on cancer; 2016.
6. Hajiyeva S, Zhong M. Pathology of Urothelial Malignancies of the Upper Urinary Tract. In: Eshghi M, ed. Urothelial Malignancies of the Upper Urinary Tract. Springer International Publishing; 2018:107-117.doi:10.1007/978-3-319-51263-1_10
7. Amin MB, Edge SB, Greene FL, et al., eds. AJCC Cancer Staging Manual. Springer International Publishing; 2017. doi:10.1007/978-3-319-40618-3
8. Lê Thị Thanh Xuân, Trịnh Tuấn Dũng. Đặc điểm mô bệnh học và sự bộc lộ các dấu ấn hóa mô miễn dịch CK20, p53, Ki67 trong ung thư biểu mô nhú đường niệu. ĐH Y Hà Nội; 2020.
9. Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA. Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma. Am J Clin Pathol. 2000; 113 (3): 383-388. doi:10.1309/G1RA-EU9X-X6VV-3W79
10. Chu P, Wu E, Weiss LM. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases. Mod Pathol. 2000; 13(9):962-972. doi:10.1038/modpathol.3880175